Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21
archived clinical trials in
Premature Ejaculation

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
GSK Investigational Site
mi
from
Anaheim, CA
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Anaheim, CA
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
GSK Investigational Site
mi
from
Indianapolis, IN
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Indianapolis, IN
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
Updated: 1/1/1970
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
GSK Investigational Site
mi
from
Philadelphia, PA
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men With Premature Ejaculation
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Philadelphia, PA
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
LA Biomedical Research Institute at Harbor-UCLA Medical Center
mi
from
Torrance, CA
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
LA Biomedical Research Institute at Harbor-UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Connecticut Clinical Research Center, LLC
mi
from
Middlebury, CT
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Research Center, LLC
mi
from
Middlebury, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Center for Marital and Sexual Health of South Florida
mi
from
West Palm Beach, FL
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Center for Marital and Sexual Health of South Florida
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Tulane University School of Medicine
mi
from
New Orleans, LA
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Tulane University School of Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Manhattan Medical Research
mi
from
New York, NY
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Manhattan Medical Research
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
San Diego Sexual Medicine
mi
from
San Diego, CA
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Belfast,
A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Belfast,
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
San Diego Sexual Medicine
mi
from
San Diego, CA
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Center for Marital and Sexual Health of South Florida
mi
from
West Palm Beach, FL
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Center for Marital and Sexual Health of South Florida
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Tulane University School of Medicine
mi
from
New Orleans, LA
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Tulane University School of Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Cooper Research Institute
mi
from
Camden, NJ
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Cooper Research Institute
mi
from
Camden, NJ
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Manhattan Medical Research
mi
from
New York, NY
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Manhattan Medical Research
mi
from
New York, NY
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
The Miriam Hospital / The Men's Health Center
mi
from
Providence, RI
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
The Miriam Hospital / The Men's Health Center
mi
from
Providence, RI
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Australian Centre for Sexual Health
mi
from
Saint Leonards,
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Australian Centre for Sexual Health
mi
from
Saint Leonards,
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Urologic Consultants of Southeastern Pennsylvania
mi
from
Bala-Cynwyd, PA
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Urologic Consultants of Southeastern Pennsylvania
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
A Phase IIb, Multi-center, Randomized, Double-blind, Placebo-controlled Study, With Open-label Follow on, to Evaluate the Efficacy, Safety and Tolerability of PSD502 in Subjects With Premature Ejaculation (PE)
Status: Enrolling
Updated:  9/2/2015
Department of Urology, University of North Carolina
mi
from
Chapel Hill, NC
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
A Phase IIb, Multi-center, Randomized, Double-blind, Placebo-controlled Study, With Open-label Follow on, to Evaluate the Efficacy, Safety and Tolerability of PSD502 in Subjects With Premature Ejaculation (PE)
Status: Enrolling
Updated: 9/2/2015
Department of Urology, University of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials